Supplies - 593578-2019

13/12/2019    S241

Norway-Vadsø: Pharmaceutical products

2019/S 241-593578

Prior information notice

This notice is for prior information only

Supplies

Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
Official name: Sykehusinnkjøp HF
National registration number: 916879067
Postal address: Postboks 40
Town: Vadsø
NUTS code: NO NORGE
Postal code: 9811
Country: Norway
Contact person: Per Ivar Rivenæs
E-mail: per.ivar.rivenaes@sykehusinnkjop.no

Internet address(es):

Main address: https://permalink.mercell.com/119353284.aspx

Address of the buyer profile: http://www.sykehusinnkjop.no/

I.2)Information about joint procurement
The contract is awarded by a central purchasing body
I.3)Communication
Additional information can be obtained from the abovementioned address
I.4)Type of the contracting authority
Body governed by public law
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

LIS 2014 Pulmonary Arterial Hypertension (PAH)

Reference number: 2019/1632
II.1.2)Main CPV code
33600000 Pharmaceutical products
II.1.3)Type of contract
Supplies
II.1.4)Short description:

On behalf of the regional health authorities (RHF), Sykehusinnkjøp HF [Norwegian Hospital Procurement Trust] will implement a procurement of medicines for the treatment of pulmonary arterial hypertension (LIS 2014 Pulmonary arterial hypertension). We therefore invite interested tenderers to dialogue meeting prior to the procurement.

II.1.5)Estimated total value
Value excluding VAT: 260 000 000.00 NOK
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.1)Title:
II.2.2)Additional CPV code(s)
II.2.3)Place of performance
NUTS code: NO01 Oslo og Akershus
II.2.4)Description of the procurement:

The Norwegian Hospital Procurement Trust, medicines division (LIS) wants to implement one-to-one meetings with the tenderers who register their interest. The dialogue meetings are intended for LIS to get information from the market, therefore LIS will not be providing information about the pending tender (LIS 2014 Pulmonary arterial hypertension). LIS will use the feedback from the dialogue meeting in the subsequent work with preparing the tender documentation. We are not in any way obliged to take all feedback into account. LIS is free to make the required requirements for covering the health trusts requirements in the tender documentation.

II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
09/03/2020

Section IV: Procedure

IV.1)Description
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: no

Section VI: Complementary information

VI.3)Additional information:
VI.5)Date of dispatch of this notice:
12/12/2019